1.0 link 220661 <![CDATA[US Opposes Transparency of Pharmaceutical Industry Economics at PAHO Meeting]]> http://www.huffingtonpost.com/james-love/us-opposes-transparency-o_b_220661.html It is not easy to make good policies on health care reform when you don't have good information. So it is surprising that the Administration is opposing a measure to have more openness about pharma industry economics.

In recent years, there has been a push for greater transparency of the pharmaceutical industry. One aspect of this concerns greater disclosures of the clinical trials on new drugs, including information about the outcomes of those trials. There are also proposals for greater disclosure...

]]> 2009-06-25T16:18:00-04:00